Antitumor activity of abiraterone, enzalutamide, and docetaxel following treatment with diethystilbestrol in castration-resistant prostate cancer.

被引：0
|
作者：
Assoun, Sandra
Campedel, Luca
Roupret, Morgan
Vaessen, Christophe
Parra, Jerome
Boostandoost, Haide Angele
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.e581
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e581
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer
    Banna, Giuseppe L.
    Urzia, Valeria
    Benanti, Chiara
    Pitre, Alessandra
    Lipari, Helga
    Di Quattro, Rosario
    De Giorgi, Ugo
    Schepisi, Giuseppe
    Basso, Umberto
    Bimbatti, Davide
    Rundo, Francesco
    Libra, Massimo
    Malatino, Lorenzo
    SUPPORTIVE CARE IN CANCER, 2020, 28 (10) : 4687 - 4695
  • [22] Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer
    Giuseppe L. Banna
    Valeria Urzia
    Chiara Benanti
    Alessandra Pitrè
    Helga Lipari
    Rosario Di Quattro
    Ugo De Giorgi
    Giuseppe Schepisi
    Umberto Basso
    Davide Bimbatti
    Francesco Rundo
    Massimo Libra
    Lorenzo Malatino
    Supportive Care in Cancer, 2020, 28 : 4687 - 4695
  • [23] Abiraterone or Enzalutamide in Advanced Castration-Resistant Prostate Cancer: An Indirect Comparison
    Chopra, Akhil
    Georgieva, Mina
    Lopes, Gilberto
    Yeo, Chong Ming
    Haaland, Benjamin
    PROSTATE, 2017, 77 (06): : 639 - 646
  • [24] The Influence of Prior Abiraterone Treatment on the Clinical Activity of Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer
    Schweizer, Michael T.
    Zhou, Xian C.
    Wang, Hao
    Bassi, Sunakshi
    Carducci, Michael A.
    Eisenberger, Mario A.
    Antonarakis, Emmanuel S.
    EUROPEAN UROLOGY, 2014, 66 (04) : 646 - 652
  • [25] Comparative effective analysis between enzalutamide and abiraterone in the treatment of metastatic castration-resistant prostate cancer
    Chopra, Akhil
    Haaland, Benjamin
    Lopes, Gilberto
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [26] Abiraterone in the treatment of metastatic castration-resistant prostate cancer
    Mostaghel, Elahe A.
    CANCER MANAGEMENT AND RESEARCH, 2014, 6 : 39 - 51
  • [27] Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
    Rodriguez-Vida, Alejo
    Galazi, Myria
    Rudman, Sarah
    Chowdhury, Simon
    Sternberg, Cora N.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3325 - 3339
  • [28] Comparison of abiraterone and enzalutamide in patients with metastatic castration-resistant prostate cancer in Taiwan
    Ni, Hsueh Fen
    Li, Jian-Ri
    INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 : 60 - 60
  • [29] The role of enzalutamide in the treatment of castration-resistant prostate cancer
    Rawlinson, Alex
    Mohammed, Aza
    Miller, Marek
    Kunkler, Roger
    FUTURE ONCOLOGY, 2012, 8 (09) : 1073 - 1081
  • [30] Effects of abiraterone in Japanese men with metastatic castration-resistant prostate cancer after enzalutamide treatment
    Iio, Hiroyuki
    Shiozaki, Keito
    Ozaki, Kisuke
    Tsujioka, Takuya
    Nishimura, Kennichi
    Fujikata, Shirou
    Tanimoto, Shuuji
    Okamoto, Kenjirou
    Yamashi, Sadamu
    Kan, Masaharu
    ANNALS OF ONCOLOGY, 2016, 27
12345